Loading…

Enhanced recovery in the resection of colorectal liver metastases

Background There is limited evidence for the use of enhanced recovery after surgery (ERAS) in patients undergoing hepatectomy, and the impact of the evolution of ERAS over time has not been examined. This study sought to evaluate the effect of an evolving ERAS program in patients undergoing hepatect...

Full description

Saved in:
Bibliographic Details
Published in:Journal of surgical oncology 2014-08, Vol.110 (2), p.197-202
Main Authors: Dunne, Declan F. J., Yip, Vincent S., Jones, Robert P., McChesney, Ewan A., Lythgoe, Daniel T., Psarelli, Eftychia E., Jones, Louise, Lacasia-Purroy, Carmen, Malik, Hassan Z., Poston, Graeme J., Fenwick, Stephen W.
Format: Article
Language:English
Subjects:
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background There is limited evidence for the use of enhanced recovery after surgery (ERAS) in patients undergoing hepatectomy, and the impact of the evolution of ERAS over time has not been examined. This study sought to evaluate the effect of an evolving ERAS program in patients undergoing hepatectomy for colorectal liver metastases (CRLM). Methods A multimodal ERAS program was introduced in 2/2008. Consecutive patients undergoing hepatectomy for CRLM between 2/2008 and 9/2012 were included in the study. Data were collected prospectively. Retrospective analysis compared an early ERAS cohort (2/2008–4/2010) with a later cohort with a matured ERAS program (5/2010–8/2012). Results Length of stay reduced as experience of ERAS increased (Log‐rank χ2 = 10.43, P = 0.001). Although median length of stay remained unchanged (6 days), the probability of hospitalization beyond 10 days was 25% in the early cohort compared with 7% in the later cohort. Critical care utilization reduced over time (75.5% vs. 54.7%, P 
ISSN:0022-4790
1096-9098
DOI:10.1002/jso.23616